Conference Name

2023 ISPE Biotechnology Conference

Time

26 - 27 Jun

Venue

Dublin, Ireland

Booth

25

2023 ISPE Biotechnology Conference will focus on unique challenges associated with innovative, biosimilar, and follow-up biotechnology products, like cell and gene therapy, Advanced Therapeutic Medicinal Products (ATMPs), and mRNA-based products - such as vaccines.

The conference will provide a leading interdisciplinary platform for all stakeholders of the pharmaceutical and biopharmaceutical supply chain to present recent innovations and trends, and openly discuss practical challenges and solutions, from a technical, logistical, and regulatory perspective.

About Pharmadule Morimatsu 

Since its establishment in 1986, Pharmadule (a member of Morimatsu Group since 2011) has delivered more than 80 production facilities in pharma and biopharma industries globally as well as completed more than 300 engineering designs and solution validations which demonstrates us as the integrated, holistic facility as well as core process equipment leading provider in the world.

We have been and continuously working with most well-known leading pharma & biopharma companies, such as Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, AstraZeneca and Lonza for their various global needs.

We will be waiting for your arrival at ISPE Biotechnology Conference.

About Morimatsu Life Science

Morimatsu Life Science is the sanitary business segment of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), covering industries such as pharmaceuticals, biopharmaceuticals, FMCG, cosmetic and electronic chemicals, and mainly includes Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) Life Technology Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Pharmadule Morimatsu AB (Sweden) and other companies and their affiliates, focusing on the R&D, manufacturing and sales of products in related fields.

Morimatsu, founded in Japan and taken root in China, has developed into a multi-national company that embraces globalization, masters core technology, and gains rich experience from project implementation in diverse fields including core equipment, process systems, and engineering solutions. Starting from its advanced manufacturing base in China, Morimatsu International has opened subsidiaries or plants in Sweden, the United States, India, Italy, Malaysia and Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by virtue of its global footprint of efficient and professional team.

Forward-Looking Statements

The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of “predicted”, “believed”, “forecast”, “planned” and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our company undertakes no obligation to constantly revise such predicted statements.

Forward-looking statements are based on our company management’s current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guaranties of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.